Quick Answer
Three unrelated mechanisms sit behind the compounds usually grouped as skin peptides. Copper complexes such as GHK-Cu and AHK-Cu carry a metal ion and are studied in the context of matrix remodelling and gene expression. Signal peptides such as Matrixyl are short matrix derived sequences, usually palmitoylated to aid penetration, studied as feedback signals to collagen producing cells. Neuropeptide analogues such as SNAP-8 are modelled on proteins involved in vesicle fusion at the neuromuscular junction. Reading a claim about one and applying it to another is the most common error in this area.
| Class | Examples | Proposed mechanism | Evidence base |
|---|---|---|---|
| Copper complexes | GHK-Cu, AHK-Cu | Copper delivery, matrix remodelling, gene expression | Broadest of the three, mostly in vitro and animal |
| Matrix signal peptides | Matrixyl (palmitoyl pentapeptide-4) | Collagen fragment mimicry signalling repair to fibroblasts | Moderate, formulation and penetration focused |
| Neuropeptide analogues | SNAP-8 | Competitive interference with SNARE complex assembly | Narrowest, mechanistic and analogy driven |
Cosmetic and dermatological peptides are sold as a single category and discussed as if they were a single mechanism. They are not. The compounds most often named together, GHK-Cu, AHK-Cu, Matrixyl and SNAP-8, are studied under three separate mechanistic models with almost nothing in common beyond being short amino acid chains. This article separates them, because the separation determines which claims in the literature transfer between compounds and which do not. Reviews draw similar lines: Gorouhi and Maibach (2009) group topical peptides into signal, carrier, neurotransmitter-inhibitor and enzyme-inhibitor peptides.
Class one: copper binding complexes
GHK is a tripeptide, glycine, histidine and lysine, first described in human serum by Pickart and Thaler (1973). Its defining property is a high affinity for copper (II); structural work by Hureau et al. (2011) shows the copper held by the terminal amino group, a backbone nitrogen and the histidine ring. The complex it forms, GHK-Cu, is the form most of the research concerns, and the copper is not incidental packaging. Copper is a cofactor for lysyl oxidase and superoxide dismutase among others, and much of the published interest in GHK-Cu concerns copper delivery, an idea dating to Pickart et al. (1980), who found the peptide increased copper uptake into cultured hepatoma cells, and the downstream consequences of that.
The published work on GHK-Cu is unusually broad for a cosmetic peptide. It spans wound healing models, extracellular matrix turnover including collagen and glycosaminoglycan synthesis, antioxidant behaviour and, more recently, gene expression data reporting changes across large numbers of genes. Collagen synthesis rose in fibroblast cultures in Maquart et al. (1988), collagen and glycosaminoglycan content rose in rat wounds in Maquart et al. (1993), and antioxidant actions are summarised by Pickart et al. (2012). The often quoted gene figure, about 31% of human genes shifted by 50% or more, comes from Pickart's analysis of the Broad Institute's Connectivity Map, a public database of responses in cultured human cell lines, rather than from fibroblast experiments, as described by Pickart and Margolina (2018). That breadth is a strength and also a trap: a great deal of it is in vitro or in animal models, and the step from a cell culture readout to a meaningful effect in intact tissue is not automatic.
AHK-Cu substitutes alanine for glycine at the first position. It keeps the histidine involved in copper binding, so similar binding is likely, but we found no comparable structural study of AHK-Cu itself. It is generally discussed in the context of hair follicle and dermal papilla research, such as the cultured human follicle work of Pyo et al. (2007), rather than the broader matrix literature that surrounds GHK. The evidence base is considerably smaller. Treating AHK-Cu as simply a variant of GHK-Cu, and importing GHK conclusions wholesale, is not supported.
Class two: matrix signal peptides
Matrixyl is the trade name most people know. The underlying compound is palmitoyl pentapeptide-4 (listed in PubChem as Pal-KTTKS), a five residue sequence derived from a fragment of type I procollagen, with palmitic acid attached.
The mechanistic idea is different from the copper class and worth understanding on its own terms. When collagen is made, the end pieces of its precursor are cut off outside the cell, and these fragments have been implicated in feedback regulation of collagen synthesis. Katayama et al. (1993) found that the pentapeptide KTTKS, from the carboxyl-terminal propeptide of type I collagen, was the minimum sequence that strongly stimulated collagen and fibronectin production in cultured fibroblasts. A synthetic peptide matching such a fragment is therefore proposed to act as a feedback signal, prompting matrix synthesis in the absence of actual damage.
The palmitoyl group is a delivery modification rather than part of the signal. The peptide alone is freely water soluble and crosses lipid rich barriers poorly, and Mortazavi et al. (2019) measured how the fatty acid tail makes it lipophilic and surface active, in other words amphiphilic. In hairless mouse skin, Choi et al. (2014) detected the palmitoylated form in all skin layers, where the unmodified peptide was not found, although neither crossed the full thickness of the skin. When you see palmitoyl at the front of a cosmetic peptide name, it is describing how the molecule is intended to get where it is going, not what it does when it arrives.
Class three: neuropeptide analogues
SNAP-8 belongs to a different world again. It is an eight residue peptide, acetyl glutamyl heptapeptide-3 (also listed as acetyl octapeptide-3), modelled on a segment of SNAP-25. Its sequence, as listed in PubChem, extends by two residues the better studied acetyl hexapeptide-3, which Wang et al. (2013) describe as patterned on the N-terminal end of SNAP-25. We found no PubMed-indexed study of SNAP-8 on its own.
SNAP-25 is a component of the SNARE complex, the machinery that docks and fuses neurotransmitter containing vesicles with the presynaptic membrane at the neuromuscular junction. The proposed mechanism for SNAP-8 is competitive: a peptide resembling part of SNAP-25 may interfere with proper assembly of that complex, reducing the efficiency of vesicle fusion. For acetyl hexapeptide-3, Blanes-Mira et al. (2002) reported interference with formation of the SNARE complex and reduced neurotransmitter release in their mechanism experiments. This is why the class is sometimes described in the literature by analogy to botulinum mechanisms, though the two operate very differently. Botulinum toxin is an enzyme that cleaves SNARE proteins; Blasi et al. (1993) showed that type A cuts SNAP-25 itself. A peptide analogue, if it acts as proposed, competes for assembly rather than destroying anything.
The important point for a researcher is categorical. This is a neurotransmission model. Nothing in the copper complex or matrix signal literature has any bearing on it, and vice versa.
Why the distinction matters when reading claims
Two practical consequences follow.
Evidence does not transfer between classes
A gene expression finding for GHK-Cu says nothing about SNAP-8. A penetration study on a palmitoylated pentapeptide says nothing about how an unmodified copper tripeptide behaves. Marketing copy routinely blends findings across all three, producing a composite claim that no single compound supports.
Formulation constraints differ
A copper complex is a metal coordination compound and its stability depends on pH and on what else is present that might compete for the copper. A palmitoylated peptide is a delivery optimised amphiphile with different solubility behaviour entirely. An acetylated octapeptide is different again. Handling and storage assumptions carried over from one class to another are not safe.
The dermatological range at Peptx
Peptx supplies GHK-Cu, AHK-Cu, GHK basic, Matrixyl, SNAP-8 and hyaluronic acid within the dermatological research category, alongside single vial formats of the copper peptides in the UK Express range.
We describe these compounds by class and by what the literature reports, without transferring findings between them. Identity and purity of what we supply are measured and published in the COA library exactly as the issuing laboratory reported them. All material is supplied strictly for laboratory research use.
Related reading
- Dermatological research range
- GHK-Cu beyond skin: regenerative research
- Why 10mg on the label is not 10mg of peptide
- Peptx COA library
- Research library
References
- Blanes-Mira C, et al. (2002). A synthetic hexapeptide (Argireline) with antiwrinkle activity. International Journal of Cosmetic Science. PubMed 18498523
- Blasi J, et al. (1993). Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature. PubMed 8103915
- Choi YL, et al. (2014). Dermal Stability and In Vitro Skin Permeation of Collagen Pentapeptides (KTTKS and palmitoyl-KTTKS). Biomolecules & Therapeutics. PubMed 25143811
- Gorouhi F, Maibach HI. (2009). Role of topical peptides in preventing or treating aged skin. International Journal of Cosmetic Science. PubMed 19570099
- Hureau C, et al. (2011). X-ray and solution structures of Cu(II) GHK and Cu(II) DAHK complexes: influence on their redox properties. Chemistry: A European Journal. PubMed 21780203
- Katayama K, et al. (1993). A pentapeptide from type I procollagen promotes extracellular matrix production. Journal of Biological Chemistry. PubMed 8486721
- Maquart FX, et al. (1988). Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Letters. PubMed 3169264
- Maquart FX, et al. (1993). In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds. Journal of Clinical Investigation. PubMed 8227353
- Mortazavi SM, et al. (2019). Effect of Palmitic Acid Conjugation on Physicochemical Properties of Peptide KTTKS: A Preformulation Study. Journal of Cosmetic Science. PubMed 31829923
- Pickart L, Thaler MM. (1973). Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nature New Biology. PubMed 4349963
- Pickart L, et al. (1980). Growth-modulating plasma tripeptide may function by facilitating copper uptake into cells. Nature. PubMed 7453802
- Pickart L, et al. (2012). The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health. Oxidative Medicine and Cellular Longevity. PubMed 22666519
- Pickart L, Margolina A. (2018). Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. PubMed 29986520
- Pyo HK, et al. (2007). The effect of tripeptide-copper complex on human hair growth in vitro. Archives of Pharmacal Research. PubMed 17703734
- Wang Y, et al. (2013). The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study. American Journal of Clinical Dermatology. PubMed 23417317
